
    
      The purpose of this prospective clinical data-collection is to document the performance and
      clinical outcomes of Pro OsteonÂ® as a Bone Void Filler. FDA has cleared this device via
      premarket notifications 510(k) K063346, K980817, and K990131. There will be no experimental
      or investigational devices used.
    
  